Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hackett

Showing results (201-210 of 260) with videos related to

Pageof 26
Sort By:
Molecular Therapy. Methods & Clinical Development|December 13, 2023
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectorsMahboubeh R Rostami, Philip L Leopold, Jenifer M Vasquez, et al.
Experimental Neurology|July 17, 2018
Injury type-dependent differentiation of NG2 glia into heterogeneous astrocytesAmber R Hackett, Stephanie L Yahn, Kirill Lyapichev, et al.
Journal of Lipid Research|July 27, 2024
Automated preparation of plasma lipids, metabolites, and proteins for LC/MS-based analysis of a high-fat diet in miceNgoc Vu, Tobias M Maile, Sudha Gollapudi, et al.
Human Gene Therapy Methods|November 8, 2012
Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosisDolan Sondhi, Linda Johnson, Keith Purpura, et al.
American Journal of Human Genetics|June 29, 2010
Population genetic structure of the people of QatarHaley Hunter-Zinck, Shaila Musharoff, Jacqueline Salit, et al.
American Journal of Respiratory Cell and Molecular Biology|February 25, 1999
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
In vivo trans-splicing of 5' and 3' segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transferRobert G Pergolizzi, Alexander E Ropper, Rachel Dragos, et al.
Plos One|November 10, 2012
Exome sequencing of only seven Qataris identifies potentially deleterious variants in the Qatari populationJuan L Rodriguez-Flores, Jennifer Fuller, Neil R Hackett, et al.
Human Gene Therapy|January 5, 2006
Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primatesNeil R Hackett, D Eugene Redmond, Dolan Sondhi, et al.
Pageof 26

Showing results (201-210 of 260) with videos related to

Sort By:
Pageof 26
Molecular Therapy. Methods & Clinical Development|December 13, 2023
Predicted deleterious variants in the human genome relevant to gene therapy with adeno-associated virus vectorsMahboubeh R Rostami, Philip L Leopold, Jenifer M Vasquez, et al.
Experimental Neurology|July 17, 2018
Injury type-dependent differentiation of NG2 glia into heterogeneous astrocytesAmber R Hackett, Stephanie L Yahn, Kirill Lyapichev, et al.
Journal of Lipid Research|July 27, 2024
Automated preparation of plasma lipids, metabolites, and proteins for LC/MS-based analysis of a high-fat diet in miceNgoc Vu, Tobias M Maile, Sudha Gollapudi, et al.
Human Gene Therapy Methods|November 8, 2012
Long-term expression and safety of administration of AAVrh.10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosisDolan Sondhi, Linda Johnson, Keith Purpura, et al.
American Journal of Human Genetics|June 29, 2010
Population genetic structure of the people of QatarHaley Hunter-Zinck, Shaila Musharoff, Jacqueline Salit, et al.
American Journal of Respiratory Cell and Molecular Biology|February 25, 1999
Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.
AJNR. American Journal of Neuroradiology|August 19, 2007
Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2003
In vivo trans-splicing of 5' and 3' segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transferRobert G Pergolizzi, Alexander E Ropper, Rachel Dragos, et al.
Plos One|November 10, 2012
Exome sequencing of only seven Qataris identifies potentially deleterious variants in the Qatari populationJuan L Rodriguez-Flores, Jennifer Fuller, Neil R Hackett, et al.
Human Gene Therapy|January 5, 2006
Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primatesNeil R Hackett, D Eugene Redmond, Dolan Sondhi, et al.
Pageof 26